Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 14/20 | 1.00 |
| ▸ | LPAR1 | Q92633 | 13/20 | 1.00 |
| ▸ | LPAR2 | Q9HBW0 | 8/20 | 0.72 |
| ▸ | LPAR5 | Q9H1C0 | 6/20 | 0.69 |
| ▸ | LPAR6 | P43657 | 5/20 | 0.56 |
| ▸ | LPAR4 | Q99677 | 5/20 | 0.56 |
| ▸ | ENPP2 | Q13822 | 5/20 | 0.51 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29458233 | 1.00 | LPAR3 (1.00) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| SCHEMBL31198159 | 1.00 | LPAR3 (1.00) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| SCHEMBL29353224 | 1.00 | LPAR3 (1.00) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| SCHEMBL30443866 | 1.00 | LPAR3 (1.00) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| SCHEMBL10896195 | 1.00 | LPAR3 (1.00) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| SCHEMBL2813163 | 1.00 | LPAR3 (1.00) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| SCHEMBL31439420 | 1.00 | LPAR3 (1.00) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| SCHEMBL496845 | 1.00 | LPAR3 (1.00) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| SCHEMBL2814732 | 1.00 | LPAR3 (1.00) | LPAR3LPAR1LPAR2LPAR5LPAR6 | |
| SCHEMBL27734843 | 1.00 | LPAR3 (1.00) | LPAR3LPAR1LPAR2LPAR5LPAR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119454649-A | Preparation method of lipid nanoparticle and complex thereof | 纳科药业科技(深圳)有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-103394102-B | Lipid micro/nano bubble, and optimized preparation method and preparation device thereof | 博信生物科技股份有限公司 | 2018-08-07 | — | — | CN | claimed |
| US-20080181928-A1 | COATINGS FOR IMPLANTABLE MEDICAL DEVICES FOR LIPOSOME DELIVERY | MIV THERAPEUTICS, INC. (CA) | 2008-07-31 | — | — | US | claimed |
| CN-120051454-A | Amino lipid compounds and lipid nanoparticles for delivery of bioactive ingredients | 深圳深信生物科技有限公司 | 2025-05-27 | — | — | CN | disclosed |
| CN-119563026-A | MRNA of novel coronavirus S protein and application thereof | 深圳深信生物科技有限公司 | 2025-03-04 | — | — | CN | disclosed |
| CN-118765271-A | Amino lipid compound, preparation method, composition and application thereof | 深圳深信生物科技有限公司 | 2024-10-11 | — | — | CN | disclosed |
| CN-118576724-A | Driven oral nano preparation for intracellular helicobacter pylori | 中国药科大学 | 2024-09-03 | — | — | CN | disclosed |
| CN-117417265-A | Lipid composition | 富士胶片株式会社 | 2024-01-19 | — | — | CN | disclosed |
| CN-109045294-A | Influenza virus immunization Immunogenic Compositions and its application | 思齐乐 | 2018-12-21 | — | — | CN | disclosed |
| CN-104853770-A | Immunogenic compositions and uses thereof | NOVARTIS AG | 2015-08-19 | — | — | CN | disclosed |
| CN-103842374-A | Pre-fusion rsv f antigens | NOVARTIS AG | 2014-06-04 | — | — | CN | disclosed |
| CN-103179989-A | Small liposomes for delivery of immunogen-encoding rna | NOVARTIS AG | 2013-06-26 | — | — | CN | disclosed |
| US-20080181928-A1 | COATINGS FOR IMPLANTABLE MEDICAL DEVICES FOR LIPOSOME DELIVERY | MIV THERAPEUTICS, INC. (CA) | 2008-07-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080181928-A1 | COATINGS FOR IMPLANTABLE MEDICAL DEVICES FOR LIPOSOME DELIVERY | LIPA, SGMS2, SGMS1 | LPAR3 214/4885LPAR1 73/4885LPAR2 39/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.